North M L, Lang J M, Bergerat J P, Giron C, Oberling F, Mayer S
Nouv Rev Fr Hematol (1978). 1984;26(5):317-21.
Heterozygous beta thalassaemia with microcytic anaemia (hemoglobin concentration 77 g/l) has been recognized in a 49 year-old woman of Alsatian extraction. A long history of microcytic anaemia had led to inadequate oral iron treatment before the patient was referred to us because of the persisting microcytic anaemia and iron loading. Indeed the patient also had haemosiderosis with a high transferrin saturation (73%) and markedly elevated ferritinaemia (1,114 micrograms/ml). Ferrokinetic data showed increased plasma iron turnover, early transfer of iron to the liver and evidence of ineffective erythropoiesis. She was treated with desferrioxamine (3 g every three days subcutaneously) and serum ferritin levels gradually decreased together with transferrin saturation. After 15 months serum ferritin and transferrin saturation were within the normal range. Several hypotheses are discussed to explain why this patient had haemosiderosis associated with heterozygous beta thalassaemia. The propositus was found to be HLA-A3, which is strongly associated with idiopathic haemochromatosis. Her sister also carries HLA-A3 with heterozygous beta thalassaemia but she has neither anaemia nor iron overload. Thus double heterozygotism is unlikely in our patient.
在一位有阿尔萨斯血统的49岁女性中,诊断出患有杂合子β地中海贫血伴小细胞贫血(血红蛋白浓度77 g/l)。该患者有长期小细胞贫血病史,在因持续性小细胞贫血和铁负荷过重被转诊至我们这里之前,接受过不充分的口服铁剂治疗。实际上,患者还患有含铁血黄素沉着症,转铁蛋白饱和度高(73%),血清铁蛋白水平显著升高(1114微克/毫升)。铁动力学数据显示血浆铁周转率增加,铁早期转移至肝脏,并有无效红细胞生成的证据。她接受了去铁胺治疗(每三天皮下注射3克),血清铁蛋白水平与转铁蛋白饱和度一起逐渐下降。15个月后,血清铁蛋白和转铁蛋白饱和度恢复到正常范围。本文讨论了几种假设,以解释该患者为何患有与杂合子β地中海贫血相关的含铁血黄素沉着症。先证者被发现携带HLA - A3,这与特发性血色素沉着症密切相关。她的姐姐也携带HLA - A3和杂合子β地中海贫血,但既无贫血也无铁过载。因此,我们的患者不太可能是双重杂合子。